APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pipeline Embolization Device (PED)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pipeline Embolization Device (PED) Market Outlook and Growth Opportunities 2026

5 July 2026194 pages

Choose your research edition.

Industry ResearchPipeline Embolization Device (PED) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pipeline Embolization Device (PED) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pipeline Embolization Device (PED) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pipeline Embolization Device (PED) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pipeline Embolization Device (PED) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pipeline Embolization Device (PED) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pipeline Embolization Device (PED) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pipeline Embolization Device (PED) market include Ascendis Health, Balt Extrusion, Boston Scientific, Codman, Evasc, Microvention, Phenox GmbH, Accumedical and ZYLOX-TONBRIDGE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pipeline Embolization Device (PED) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pipeline Embolization Device (PED) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pipeline Embolization Device (PED) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pipeline Embolization Device (PED) market size, projected growth trends, production technologies, key applications, and end-use industries.

Pipeline Embolization Device (PED) Segment by Company

Ascendis Health

Balt Extrusion

Boston Scientific

Codman

Evasc

Microvention

Phenox GmbH

Accumedical

ZYLOX-TONBRIDGE

Medtronic

Johnson & Johnson

Stryker Corporation

MicroPort

Pipeline Embolization Device (PED) Segment by Type

48 Alloy Wire Braided

64 Alloy Wire Braided

Other

Pipeline Embolization Device (PED) Segment by Application

Intracranial Aneurysm Treatment

Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)

Other

Pipeline Embolization Device (PED) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pipeline Embolization Device (PED) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pipeline Embolization Device (PED) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pipeline Embolization Device (PED) significant trends, drivers, influence factors in global and regions.

6. To analyze Pipeline Embolization Device (PED) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pipeline Embolization Device (PED) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pipeline Embolization Device (PED) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pipeline Embolization Device (PED).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pipeline Embolization Device (PED) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pipeline Embolization Device (PED) industry.

Chapter 3: Detailed analysis of Pipeline Embolization Device (PED) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pipeline Embolization Device (PED) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pipeline Embolization Device (PED) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pipeline Embolization Device (PED) Industry Trends Table 2. Pipeline Embolization Device (PED) Industry Drivers Table 3. Pipeline Embolization Device (PED) Industry Opportunities and Challenges Table 4. Pipeline Embolization Device (PED) Industry Restraints Table 5. Global Pipeline Embolization Device (PED) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pipeline Embolization Device (PED) Revenue Share by Company (2021-2026) Table 7. Global Pipeline Embolization Device (PED) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pipeline Embolization Device (PED) Sales Volume Share by Company (2021-2026) Table 9. Global Pipeline Embolization Device (PED) Average Price (USD/unit) of Company (2021-2026) Table 10. Global Pipeline Embolization Device (PED) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pipeline Embolization Device (PED) Key Company Manufacturing Base & Headquarters Table 12. Global Pipeline Embolization Device (PED) Company, Product Type & Application Table 13. Global Pipeline Embolization Device (PED) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pipeline Embolization Device (PED) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 48 Alloy Wire Braided Table 18. Significant Companies of 64 Alloy Wire Braided Table 19. Significant Companies of Other Table 20. Global Pipeline Embolization Device (PED) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Pipeline Embolization Device (PED) Sales Volume by Type (2021-2026) & (k units) Table 22. Global Pipeline Embolization Device (PED) Sales Volume by Type (2027-2032) & (k units) Table 23. Global Pipeline Embolization Device (PED) Sales Volume Share by Type (2021-2026) Table 24. Global Pipeline Embolization Device (PED) Sales Volume Share by Type (2027-2032) Table 25. Global Pipeline Embolization Device (PED) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pipeline Embolization Device (PED) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Pipeline Embolization Device (PED) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Pipeline Embolization Device (PED) Sales Value Share by Type (2021-2026) Table 29. Global Pipeline Embolization Device (PED) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Intracranial Aneurysm Treatment Table 31. Significant Companies of Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.) Table 32. Significant Companies of Other Table 33. Global Pipeline Embolization Device (PED) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Pipeline Embolization Device (PED) Sales Volume by Application (2021-2026) & (k units) Table 35. Global Pipeline Embolization Device (PED) Sales Volume by Application (2027-2032) & (k units) Table 36. Global Pipeline Embolization Device (PED) Sales Volume Share by Application (2021-2026) Table 37. Global Pipeline Embolization Device (PED) Sales Volume Share by Application (2027-2032) Table 38. Global Pipeline Embolization Device (PED) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pipeline Embolization Device (PED) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pipeline Embolization Device (PED) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pipeline Embolization Device (PED) Sales Value Share by Application (2021-2026) Table 42. Global Pipeline Embolization Device (PED) Sales Value Share by Application (2027-2032) Table 43. Global Pipeline Embolization Device (PED) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Pipeline Embolization Device (PED) Sales by Region (2021-2026) & (k units) Table 45. Global Pipeline Embolization Device (PED) Sales Market Share by Region (2021-2026) Table 46. Global Pipeline Embolization Device (PED) Sales by Region (2027-2032) & (k units) Table 47. Global Pipeline Embolization Device (PED) Sales Market Share by Region (2027-2032) Table 48. Global Pipeline Embolization Device (PED) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pipeline Embolization Device (PED) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pipeline Embolization Device (PED) Sales Value Share by Region (2021-2026) Table 51. Global Pipeline Embolization Device (PED) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pipeline Embolization Device (PED) Sales Value Share by Region (2027-2032) Table 53. Global Pipeline Embolization Device (PED) Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Pipeline Embolization Device (PED) Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Pipeline Embolization Device (PED) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Pipeline Embolization Device (PED) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 58. Global Pipeline Embolization Device (PED) Sales Market Share by Country (2021-2026) Table 59. Global Pipeline Embolization Device (PED) Sales by Country (2027-2032) & (k units) Table 60. Global Pipeline Embolization Device (PED) Sales Market Share by Country (2027-2032) Table 61. Global Pipeline Embolization Device (PED) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pipeline Embolization Device (PED) Sales Value Market Share by Country (2021-2026) Table 63. Global Pipeline Embolization Device (PED) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pipeline Embolization Device (PED) Sales Value Market Share by Country (2027-2032) Table 65. Ascendis Health Company Information Table 66. Ascendis Health Business Overview Table 67. Ascendis Health Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Ascendis Health Pipeline Embolization Device (PED) Product Portfolio Table 69. Ascendis Health Recent Development Table 70. Balt Extrusion Company Information Table 71. Balt Extrusion Business Overview Table 72. Balt Extrusion Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio Table 74. Balt Extrusion Recent Development Table 75. Boston Scientific Company Information Table 76. Boston Scientific Business Overview Table 77. Boston Scientific Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Boston Scientific Pipeline Embolization Device (PED) Product Portfolio Table 79. Boston Scientific Recent Development Table 80. Codman Company Information Table 81. Codman Business Overview Table 82. Codman Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Codman Pipeline Embolization Device (PED) Product Portfolio Table 84. Codman Recent Development Table 85. Evasc Company Information Table 86. Evasc Business Overview Table 87. Evasc Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Evasc Pipeline Embolization Device (PED) Product Portfolio Table 89. Evasc Recent Development Table 90. Microvention Company Information Table 91. Microvention Business Overview Table 92. Microvention Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Microvention Pipeline Embolization Device (PED) Product Portfolio Table 94. Microvention Recent Development Table 95. Phenox GmbH Company Information Table 96. Phenox GmbH Business Overview Table 97. Phenox GmbH Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio Table 99. Phenox GmbH Recent Development Table 100. Accumedical Company Information Table 101. Accumedical Business Overview Table 102. Accumedical Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Accumedical Pipeline Embolization Device (PED) Product Portfolio Table 104. Accumedical Recent Development Table 105. ZYLOX-TONBRIDGE Company Information Table 106. ZYLOX-TONBRIDGE Business Overview Table 107. ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio Table 109. ZYLOX-TONBRIDGE Recent Development Table 110. Medtronic Company Information Table 111. Medtronic Business Overview Table 112. Medtronic Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Medtronic Pipeline Embolization Device (PED) Product Portfolio Table 114. Medtronic Recent Development Table 115. Johnson & Johnson Company Information Table 116. Johnson & Johnson Business Overview Table 117. Johnson & Johnson Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio Table 119. Johnson & Johnson Recent Development Table 120. Stryker Corporation Company Information Table 121. Stryker Corporation Business Overview Table 122. Stryker Corporation Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio Table 124. Stryker Corporation Recent Development Table 125. MicroPort Company Information Table 126. MicroPort Business Overview Table 127. MicroPort Pipeline Embolization Device (PED) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. MicroPort Pipeline Embolization Device (PED) Product Portfolio Table 129. MicroPort Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Pipeline Embolization Device (PED) Distributors List Table 133. Pipeline Embolization Device (PED) Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Pipeline Embolization Device (PED) Product Image Figure 2. Global Pipeline Embolization Device (PED) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pipeline Embolization Device (PED) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pipeline Embolization Device (PED) Sales (2021-2032) & (k units) Figure 5. Global Pipeline Embolization Device (PED) Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Pipeline Embolization Device (PED) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 48 Alloy Wire Braided Image Figure 10. 64 Alloy Wire Braided Image Figure 11. Other Image Figure 12. Global Pipeline Embolization Device (PED) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Pipeline Embolization Device (PED) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Pipeline Embolization Device (PED) Sales Volume Share by Type (2021-2032) Figure 15. Global Pipeline Embolization Device (PED) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pipeline Embolization Device (PED) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pipeline Embolization Device (PED) Sales Value Share by Type (2021-2032) Figure 18. Intracranial Aneurysm Treatment Image Figure 19. Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.) Image Figure 20. Other Image Figure 21. Global Pipeline Embolization Device (PED) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Pipeline Embolization Device (PED) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pipeline Embolization Device (PED) Sales Volume Share by Application (2021-2032) Figure 24. Global Pipeline Embolization Device (PED) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pipeline Embolization Device (PED) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pipeline Embolization Device (PED) Sales Value Share by Application (2021-2032) Figure 27. Global Pipeline Embolization Device (PED) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Pipeline Embolization Device (PED) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pipeline Embolization Device (PED) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pipeline Embolization Device (PED) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pipeline Embolization Device (PED) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pipeline Embolization Device (PED) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pipeline Embolization Device (PED) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pipeline Embolization Device (PED) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pipeline Embolization Device (PED) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pipeline Embolization Device (PED) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pipeline Embolization Device (PED) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pipeline Embolization Device (PED) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pipeline Embolization Device (PED) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pipeline Embolization Device (PED) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pipeline Embolization Device (PED) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pipeline Embolization Device (PED) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 48 Alloy Wire Braided
  • 64 Alloy Wire Braided
  • Other
Applications
  • Intracranial Aneurysm Treatment
  • Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
  • Other
Companies covered
  • Ascendis Health
  • Balt Extrusion
  • Boston Scientific
  • Codman
  • Evasc
  • Microvention
  • Phenox GmbH
  • Accumedical
  • ZYLOX-TONBRIDGE
  • Medtronic
  • Johnson & Johnson
  • Stryker Corporation
  • MicroPort

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pipeline Embolization Device (PED) Sales Value (2021-2032)
  4. 1.2.2 Global Pipeline Embolization Device (PED) Sales Volume (2021-2032)
  5. 1.2.3 Global Pipeline Embolization Device (PED) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pipeline Embolization Device (PED) Market Dynamics
  1. 2.1 Pipeline Embolization Device (PED) Industry Trends
  2. 2.2 Pipeline Embolization Device (PED) Industry Drivers
  3. 2.3 Pipeline Embolization Device (PED) Industry Opportunities and Challenges
  4. 2.4 Pipeline Embolization Device (PED) Industry Restraints
3 Pipeline Embolization Device (PED) Market by Company
  1. 3.1 Global Pipeline Embolization Device (PED) Company Revenue Ranking in 2025
  2. 3.2 Global Pipeline Embolization Device (PED) Revenue by Company (2021-2026)
  3. 3.3 Global Pipeline Embolization Device (PED) Sales Volume by Company (2021-2026)
  4. 3.4 Global Pipeline Embolization Device (PED) Average Price by Company (2021-2026)
  5. 3.5 Global Pipeline Embolization Device (PED) Company Ranking (2024-2026)
  6. 3.6 Global Pipeline Embolization Device (PED) Company Manufacturing Base and Headquarters
  7. 3.7 Global Pipeline Embolization Device (PED) Company Product Type and Application
  8. 3.8 Global Pipeline Embolization Device (PED) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pipeline Embolization Device (PED) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pipeline Embolization Device (PED) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pipeline Embolization Device (PED) Market by Type
  1. 4.1 Pipeline Embolization Device (PED) Type Introduction
  2. 4.1.1 48 Alloy Wire Braided
  3. 4.1.2 64 Alloy Wire Braided
  4. 4.1.3 Other
  5. 4.2 Global Pipeline Embolization Device (PED) Sales Volume by Type
  6. 4.2.1 Global Pipeline Embolization Device (PED) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pipeline Embolization Device (PED) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Pipeline Embolization Device (PED) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Pipeline Embolization Device (PED) Sales Value by Type
  10. 4.3.1 Global Pipeline Embolization Device (PED) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pipeline Embolization Device (PED) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Pipeline Embolization Device (PED) Sales Value Share by Type (2021-2032)
5 Pipeline Embolization Device (PED) Market by Application
  1. 5.1 Pipeline Embolization Device (PED) Application Introduction
  2. 5.1.1 Intracranial Aneurysm Treatment
  3. 5.1.2 Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
  4. 5.1.3 Other
  5. 5.2 Global Pipeline Embolization Device (PED) Sales Volume by Application
  6. 5.2.1 Global Pipeline Embolization Device (PED) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pipeline Embolization Device (PED) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pipeline Embolization Device (PED) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pipeline Embolization Device (PED) Sales Value by Application
  10. 5.3.1 Global Pipeline Embolization Device (PED) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pipeline Embolization Device (PED) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pipeline Embolization Device (PED) Sales Value Share by Application (2021-2032)
6 Pipeline Embolization Device (PED) Regional Sales and Value Analysis
  1. 6.1 Global Pipeline Embolization Device (PED) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pipeline Embolization Device (PED) Sales by Region (2021-2032)
  3. 6.2.1 Global Pipeline Embolization Device (PED) Sales by Region: 2021-2026
  4. 6.2.2 Global Pipeline Embolization Device (PED) Sales by Region (2027-2032)
  5. 6.3 Global Pipeline Embolization Device (PED) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pipeline Embolization Device (PED) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pipeline Embolization Device (PED) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pipeline Embolization Device (PED) Sales Value by Region (2027-2032)
  9. 6.5 Global Pipeline Embolization Device (PED) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pipeline Embolization Device (PED) Sales Value (2021-2032)
  12. 6.6.2 North America Pipeline Embolization Device (PED) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pipeline Embolization Device (PED) Sales Value (2021-2032)
  15. 6.7.2 Europe Pipeline Embolization Device (PED) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pipeline Embolization Device (PED) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pipeline Embolization Device (PED) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pipeline Embolization Device (PED) Sales Value (2021-2032)
  21. 6.9.2 South America Pipeline Embolization Device (PED) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pipeline Embolization Device (PED) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pipeline Embolization Device (PED) Sales Value Share by Country, 2025 VS 2032
7 Pipeline Embolization Device (PED) Country-level Sales and Value Analysis
  1. 7.1 Global Pipeline Embolization Device (PED) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pipeline Embolization Device (PED) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pipeline Embolization Device (PED) Sales by Country (2021-2032)
  4. 7.3.1 Global Pipeline Embolization Device (PED) Sales by Country (2021-2026)
  5. 7.3.2 Global Pipeline Embolization Device (PED) Sales by Country (2027-2032)
  6. 7.4 Global Pipeline Embolization Device (PED) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pipeline Embolization Device (PED) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pipeline Embolization Device (PED) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pipeline Embolization Device (PED) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pipeline Embolization Device (PED) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pipeline Embolization Device (PED) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ascendis Health
  2. 8.1.1 Ascendis Health Company Information
  3. 8.1.2 Ascendis Health Business Overview
  4. 8.1.3 Ascendis Health Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ascendis Health Pipeline Embolization Device (PED) Product Portfolio
  6. 8.1.5 Ascendis Health Recent Developments
  7. 8.2 Balt Extrusion
  8. 8.2.1 Balt Extrusion Company Information
  9. 8.2.2 Balt Extrusion Business Overview
  10. 8.2.3 Balt Extrusion Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio
  12. 8.2.5 Balt Extrusion Recent Developments
  13. 8.3 Boston Scientific
  14. 8.3.1 Boston Scientific Company Information
  15. 8.3.2 Boston Scientific Business Overview
  16. 8.3.3 Boston Scientific Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boston Scientific Pipeline Embolization Device (PED) Product Portfolio
  18. 8.3.5 Boston Scientific Recent Developments
  19. 8.4 Codman
  20. 8.4.1 Codman Company Information
  21. 8.4.2 Codman Business Overview
  22. 8.4.3 Codman Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Codman Pipeline Embolization Device (PED) Product Portfolio
  24. 8.4.5 Codman Recent Developments
  25. 8.5 Evasc
  26. 8.5.1 Evasc Company Information
  27. 8.5.2 Evasc Business Overview
  28. 8.5.3 Evasc Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Evasc Pipeline Embolization Device (PED) Product Portfolio
  30. 8.5.5 Evasc Recent Developments
  31. 8.6 Microvention
  32. 8.6.1 Microvention Company Information
  33. 8.6.2 Microvention Business Overview
  34. 8.6.3 Microvention Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Microvention Pipeline Embolization Device (PED) Product Portfolio
  36. 8.6.5 Microvention Recent Developments
  37. 8.7 Phenox GmbH
  38. 8.7.1 Phenox GmbH Company Information
  39. 8.7.2 Phenox GmbH Business Overview
  40. 8.7.3 Phenox GmbH Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio
  42. 8.7.5 Phenox GmbH Recent Developments
  43. 8.8 Accumedical
  44. 8.8.1 Accumedical Company Information
  45. 8.8.2 Accumedical Business Overview
  46. 8.8.3 Accumedical Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Accumedical Pipeline Embolization Device (PED) Product Portfolio
  48. 8.8.5 Accumedical Recent Developments
  49. 8.9 ZYLOX-TONBRIDGE
  50. 8.9.1 ZYLOX-TONBRIDGE Company Information
  51. 8.9.2 ZYLOX-TONBRIDGE Business Overview
  52. 8.9.3 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio
  54. 8.9.5 ZYLOX-TONBRIDGE Recent Developments
  55. 8.10 Medtronic
  56. 8.10.1 Medtronic Company Information
  57. 8.10.2 Medtronic Business Overview
  58. 8.10.3 Medtronic Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Medtronic Pipeline Embolization Device (PED) Product Portfolio
  60. 8.10.5 Medtronic Recent Developments
  61. 8.11 Johnson & Johnson
  62. 8.11.1 Johnson & Johnson Company Information
  63. 8.11.2 Johnson & Johnson Business Overview
  64. 8.11.3 Johnson & Johnson Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio
  66. 8.11.5 Johnson & Johnson Recent Developments
  67. 8.12 Stryker Corporation
  68. 8.12.1 Stryker Corporation Company Information
  69. 8.12.2 Stryker Corporation Business Overview
  70. 8.12.3 Stryker Corporation Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio
  72. 8.12.5 Stryker Corporation Recent Developments
  73. 8.13 MicroPort
  74. 8.13.1 MicroPort Company Information
  75. 8.13.2 MicroPort Business Overview
  76. 8.13.3 MicroPort Pipeline Embolization Device (PED) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 MicroPort Pipeline Embolization Device (PED) Product Portfolio
  78. 8.13.5 MicroPort Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pipeline Embolization Device (PED) Value Chain Analysis
  2. 9.1.1 Pipeline Embolization Device (PED) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pipeline Embolization Device (PED) Sales Mode & Process
  6. 9.2 Pipeline Embolization Device (PED) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pipeline Embolization Device (PED) Distributors
  9. 9.2.3 Pipeline Embolization Device (PED) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst